| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Perspective Therapeutics, Inc. (CATX) has 8 insiders with recent SEC Form 4 filings, including 25 buys and 0 sells. CATX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 735.0K | $2.21M | - | |
| CFO | 600.0K | $1.80M | - | |
| Other | 150.0K | $450.0K | - | |
| Other | 90.0K | $270.0K | - | |
| Dir | 75.0K | $225.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Spoor Johan M. | CEO | Buy | 26,500 | $3.79 | $100,468.00 | +13.4% | -26.0% | -40.7% | |
| Jun 17, 2024 | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 1,800 | $9.82 | $17,667.00 | +5.3% | +26.9% | -65.9% | |
| Jun 14, 2024 | Woods Lori A70 | Director | Buy | 4,587 | $10.90 | $49,990.00 | +1.5% | +48.0% | -70.4% | |
| Jun 13, 2024 | Spoor Johan M. | CEO | Buy | 100,000 | $1.17 | $117,430.00 | +266.2% | +34.9% | -72.7% | |
| Jun 3, 2024 | Woods Lori A70 | Director | Buy | 34,246 | $1.46 | $49,992.31 | +2.3% | +3.5% | -77.4% | |
| May 31, 2024 | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 25,006 | $1.40 | $35,007.10 | +3.9% | +12.9% | -81.4% | |
| May 31, 2024 | Williamson Robert F III63 | Director | Buy | 55,000 | $1.38 | $75,900.00 | +14.9% | +12.9% | -81.4% | |
| May 29, 2024 | Williamson Robert F III63 | Director | Buy | 30,031 | $1.33 | $40,014.04 | +4.4% | +13.3% | -80.0% | |
| Jan 30, 2024 | Williamson Robert F III63 | Director | Buy | 127,206 | $0.71 | $90,710.05 | +9.8% | +118.4% | -51.9% | |
| Jan 29, 2024 | Williamson Robert F III63 | Director | Buy | 135,879 | $0.58 | $78,473.91 | +15.3% | +144.0% | -45.5% |